{"product_id":"acg-annual-scientific-meeting-2021","title":"ACG Annual Scientific Meeting 2021","description":"\u003cdiv class=\"prod-title\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv id=\"block-pagetitle\"\u003e\n\u003ch1 class=\"product-title product_title entry-title\"\u003eACG Annual Scientific Meeting 2021\u003c\/h1\u003e\n\u003cp\u003eACG Annual Scientific Meeting 2021\u003c\/p\u003e\n\u003ctable class=\"table table-schedule\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd class=\"h3 text-uppercase\"\u003e\u003cb\u003eMonday, October 25, 2021 | 7:50 am – 6:30 pm\u003c\/b\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:50 am\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eOpening Remarks\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eDavid A. Greenwald, MD, FACG, ACG President\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:00 am\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePresidential Plenary Session 1\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerators: David A. Greenwald, MD, FACG, and Brooks D. Cash, MD, FACG\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:00 am\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePresident’s Address\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eDavid A. Greenwald, MD, FACG, ACG President\u003c\/em\u003e\u003cbr\u003e\n\u003cem\u003eIntroduced by: Samir A. Shah, MD, FACG, ACG President-Elect\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:30 am\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePresidential Plenary Session 2\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerators: Samir A. Shah, MD, FACG, and Brooks D. Cash, MD, FACG\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:00 am\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eExhibit Hall Opens\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:15 am\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eHands-On Endoscopy Workshop Center Opens\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:30 am\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eKeynote Address by Dr. Thomas Frieden\u003c\/strong\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eCOVID, Colons and Collective Action: What’s New for Health and Health Care in the U.S. and Globally\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eThomas R. Frieden, MD, MPH\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:30 am\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eScientific Poster Session Opens\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:30 am\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBreak – Visit the Exhibit Hall and Browse Scientific Posters\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:30 am\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eExhibitor Theater\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:30 am\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eSimultaneous Symposia: Session 1\u003cbr\u003e\n\u003csmall\u003eIn-person attendees can choose from three simultaneous symposia. One of the three symposia will be livestreamed for virtual attendees to view. All attendees will have access to on-demand recordings from each symposium following the conference.\u003c\/small\u003e\u003c\/strong\u003e\n\u003cp class=\"m-b-0\"\u003e\n\u003c\/p\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium 1A: ACG Past Presidents’ Symposium\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eModerator: Sunanda V. Kane, MD, MSPH, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eIntestinal Dysbiosis and Recurrent \u003cem\u003eC. difficile\u003c\/em\u003e: Impact and Clinical Solutions\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003ePast President: Christina M. Surawicz, MD, MACG\u003cbr\u003e\nJessica R. Allegretti, MD, MPH\u003c\/em\u003e\u003cbr\u003e\nDiscuss and apply emerging therapeutic options for dysbiosis and recurrent \u003cem\u003eC. difficile\u003c\/em\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNew Technologies in GERD and How to Use Them in the Clinical Setting\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003ePast President: Joel E. Richter, MD, MACG\u003cbr\u003e\nMarcelo F. Vela, MD, MSCR, FACG\u003c\/em\u003e\u003cbr\u003e\nRecognize evolving technologies in GERD and how to use them in the clinical setting.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImproving Access, Acceptability, Quality, and Cost-Effectiveness of Colon Cancer Screening\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003ePast President: Mark B. Pochapin, MD, FACG\u003cbr\u003e\nJohn M. Inadomi, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nAppraise and apply contemporary best evidence in the management of colon cancer screening.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium 1B: Complications of Advanced Liver Disease\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Norah A. Terrault, MD, MPH, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eUpdates in Current Management of Ascites, SBP, and HRS\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eJasmohan S. Bajaj, MD, MSc, FACG\u003c\/em\u003e\u003cbr\u003e\nDiscuss best practices in the evaluation of abdominal ascites, spontaneous bacterial peritonitis, and acute kidney injury in patients with liver cirrhosis, and apply current evidence-based guideline recommendations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUpdate in Liver Transplantation: Implications for the GI Provider\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eNorah A. Terrault, MD, MPH, FACG\u003c\/em\u003e\u003cbr\u003e\nSummarize new UNOS policies governing organ allocation for liver transplantation, and outline evidence-based recommendations for the general gastroenterologist caring for patients both pre- and post-transplantation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCurrent Concepts in the Management of Hepatic Encephalopathy\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eR. Todd Frederick, MD\u003c\/em\u003e\u003cbr\u003e\nReview current and evolving guidelines for the diagnosis and management of occult and overt hepatic encephalopathy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium 1C: Update on Endoscopic Resection of Colorectal Lesions\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Tonya R. Kaltenbach, MD, MS, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eOptical Diagnosis of Benign and Malignant Colorectal Lesions\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eSarah K. McGill, MD\u003c\/em\u003e\u003cbr\u003e\nIdentify the signature features of benign and malignant colorectal lesions and apply classifications to enhance real-time histologic prediction of lesions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCold Snare Polypectomy for Complete Removal of Small Colorectal Lesions\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eSwati G. Patel, MD\u003c\/em\u003e\u003cbr\u003e\nDiscuss the updated USMSTF recommendations on optimal polypectomy techniques for small colorectal lesions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEMR of Large Colorectal Lesions\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eTonya R. Kaltenbach, MD, MS, FACG\u003c\/em\u003e\u003cbr\u003e\nDescribe the techniques for endoscopic mucosal resection of large colon polyps, and identify best practices including when to refer to a specialist.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrevention and Management of Large Polyp Resection Complications\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eDouglas K. Rex, MD, MACG\u003c\/em\u003e\u003cbr\u003e\nIdentify methods to prevent and manage complications of large polyp resection.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuality and Competency in Colorectal Lesion Removal: Training and Sustaining\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eRoy M. Soetikno, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nSummarize competency learning curves and optimal training strategies for colorectal lesion removal, including simulation-based learning.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:45 pm\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eLunch Break – Visit the Exhibit Hall and Browse Scientific Posters\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:45 pm\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eACG – FDA Public Forum\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:45 pm\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eExhibitor Theater\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1:00 pm\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eScientific Poster Session – Authors Present\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1:40 pm\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eExhibitor Theater\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2:15 pm\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eSimultaneous Plenary Sessions 1\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3:05 pm\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e\u003cem\u003eThe American Journal of Gastroenterology\u003c\/em\u003e Lecture\u003c\/strong\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eHidden in Plain Sight: Bringing Women Into the Scope of Gastroenterology\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003ePresenter: Amy S. Oxentenko, MD, FACG\u003cbr\u003e\nIntroduced by: Brian E. Lacy, MD, PhD, FACG, and Brennan M. Spiegel, MD, MSHS, FACG\u003c\/em\u003e\u003cbr\u003e\nDetail the impact of women in the course of history of medicine and gastroenterology.\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3:45 pm\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eHow to Get Published: ACG Journal Editors’ Roundtable\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eBrian E. Lacy, MD, PhD, FACG, Brennan M. Spiegel, MD, MSHS, FACG, and Brian C. Jacobson, MD, MPH\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3:45 pm\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBreak – Visit the Exhibit Hall and Browse Scientific Posters\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3:45 pm\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eExhibitor Theater\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4:45 pm\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eSimultaneous Symposia: Session 2\u003cbr\u003e\n\u003csmall\u003eIn-person attendees can choose from three simultaneous symposia. One of the three symposia will be livestreamed for virtual attendees to view. All attendees will have access to on-demand recordings from each symposium following the conference.\u003c\/small\u003e\u003c\/strong\u003e\n\u003cp class=\"m-b-0\"\u003e\n\u003c\/p\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium 2A: Starting, Switching, and Stopping Therapy in IBD\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Christina Y. Ha, MD, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStarting Therapy in IBD\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eBincy P. Abraham, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nSummarize treatment strategies for initiating therapy in mild and moderate-severe Crohn’s disease and ulcerative colitis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSwitching Therapy in IBD\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eRaymond K. Cross, MD, MS, FACG\u003c\/em\u003e\u003cbr\u003e\nDecide when to switch within and out of medication class in IBD, including loss of response, immunogenicity, adverse events, and biosimilars.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStopping and De-Escalating Therapy in IBD\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eChristina Y. Ha, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nDescribe a practical approach to de-escalation and monitoring of IBD therapy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium 2B: ACG Clinical Guideline: Management of Irritable Bowel Syndrome\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Brian E. Lacy, MD, PhD, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eIBS — Making the Diagnosis\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eBrian E. Lacy, MD, PhD, FACG\u003c\/em\u003e\u003cbr\u003e\nDiscuss the ACG guideline recommendations for diagnostic testing in irritable bowel syndrome.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePharmacotherapy of IBS\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eDarren M. Brenner, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nDescribe the rationale for ACG guideline recommendations for pharmacologic therapy for irritable bowel syndrome.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNon-Pharmacologic Treatment Options for IBS\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eBaharak Moshiree, MD, MSc\u003c\/em\u003e\u003cbr\u003e\nInterpret the latest ACG guidelines as they relate to the non-pharmacologic management of IBS patients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium 2C: Live From Las Vegas! The 9th Annual Endoscopy Video Forum\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eModerators: Seth A. Gross, MD, FACG, and Vivek Kaul, MD, FACG\u003cbr\u003e\nJudges: David J. Hass, MD, FACG; Laith H. Jamil, MD, FACG; Pichamol Jirapinyo, MD, MPH; Shivangi T. Kothari, MD, FACG; Saowanee Ngamruengphong, MD; Kevin E. Woods, MD, MPH\u003c\/em\u003e\u003cbr\u003e\nDemonstrate interesting endoscopic findings and techniques encountered in daily clinical practice.\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6:00 pm\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eACG’s Annual Business Meeting\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eAll Members and Fellows of ACG are invited.\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6:30 pm\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eAnnual Scientific Meeting Adjourns for the Day\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ctable class=\"table table-schedule\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003e\u003c\/th\u003e\n\u003cth class=\"h3 text-uppercase\"\u003eTuesday, October 26, 2021 | 8:30 am – 6:25 pm\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e8:30 am\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eSimultaneous Plenary Sessions 2\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e10:00 am\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eExhibit Hall Opens\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e10:05 am\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eHands-On Endoscopy Workshop Center Opens\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e10:05 am\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eJ. Edward Berk Distinguished Lecture\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003ePresenter: William D. Chey, MD, FACG\u003cbr\u003e\n\u003c\/em\u003e\u003cem\u003eIntroduced By: David A. Greenwald, MD, FACG, ACG President\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e10:35 am\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eScientific Poster Session Opens\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e10:35 am\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBreak – Visit the Exhibit Hall and Browse Scientific Posters\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e10:35 am\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eExhibitor Theater\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e11:30 am\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eSimultaneous Symposia: Session 3\u003cbr\u003e\n\u003csmall\u003eIn-person attendees can choose from three simultaneous symposia. One of the three symposia will be livestreamed for virtual attendees to view. All attendees will have access to on-demand recordings from each symposium following the conference.\u003c\/small\u003e\u003c\/strong\u003e\n\u003cp class=\"m-b-0\"\u003e\n\u003c\/p\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium 3A: Updates on CRC Screening and Surveillance\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Charles J. Kahi, MD, MSc, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAt What Age Should I Start Screening and When Should I Stop?\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eAasma Shaukat, MD, MPH, FACG\u003c\/em\u003e\u003cbr\u003e\nReview the evidence of more aggressive, earlier colorectal cancers to support clinical guidelines for screening.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHow to Inform Patient Screening Choice in the Context of COVID\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eCharles J. Kahi, MD, MSc, FACG\u003c\/em\u003e\u003cbr\u003e\nDefine screening test characteristic performances for adenoma, advanced adenoma, and cancer by stage; and highlight shifts, barriers, and facilitators to high-quality screening during a pandemic.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHow to Incorporate the New CRC Surveillance Recommendations Into Practice\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eSamir Gupta, MD\u003c\/em\u003e\u003cbr\u003e\nSummarize post-polypectomy surveillance recommendations, including major changes from the prior recommendations, and outline evidence-based surveillance practices.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium 3B: The Latest in the A-Zs of Acute Pancreatitis\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Linda S. Lee, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eManaging Acute Pancreatitis in the First 24 Hours\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eBechien U. Wu, MD\u003c\/em\u003e\u003cbr\u003e\nExplain how to diagnose and risk stratify patients with acute pancreatitis, and identify key components in early management including fluids, diet, pain control, antibiotic use, and monitoring for compartment syndrome.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManaging Complications of Acute Pancreatitis Including Leaks and Collections\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eLinda S. Lee, MD\u003c\/em\u003e\u003cbr\u003e\nDescribe common complications of acute pancreatitis that can be managed endoscopically, including pseudocysts, walled-off necrosis and pancreatic duct leaks, and recognize optimal treatment approaches for these conditions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIdiopathic Recurrent Acute Pancreatitis: How to Evaluate and Manage\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eDarwin L. Conwell, MD, MS, FACG\u003c\/em\u003e\u003cbr\u003e\nDiscuss work-up for diagnosing the etiology of idiopathic recurrent acute pancreatitis, and outline medical and endoscopic management.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium 3C: Gastric Disorders: Burning Issues in 2021\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Colin W. Howden, MD, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAcid-Peptic Disorders: What’s New in 2021?\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eColin W. Howden, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nIdentify new therapeutic options for acid-peptic disorders.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUpdate in Gastroparesis and Functional Dyspepsia\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eBraden Kuo, MD\u003c\/em\u003e\u003cbr\u003e\nExplain medical and surgical therapies for motility and functional disorders of the stomach.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePolyps and Nodules of the Stomach: When to Survey, Resect, or Refer for EUS\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eSaowanee Ngamruengphong, MD\u003c\/em\u003e\u003cbr\u003e\nSummarize the latest diagnostic and management approaches to polyps and nodules of the stomach.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e12:45 pm\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eLunch Break – Visit Exhibit Hall and Browse Scientific Posters\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e12:45 pm\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eExhibitor Theater\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e1:00 pm\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eScientific Poster Session – Authors Present\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e1:40 pm\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eExhibitor Theater\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e2:15 pm \u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eSimultaneous Plenary Sessions 3\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e3:45 pm\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBreak – Visit Exhibit Hall and Browse Scientific Posters\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e4:30 pm\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eEmily Couric Memorial Lecture\u003c\/strong\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eChanging the Narrative on Colorectal Cancer Prevention: Translating Stories to Partnership, Policy, and Practice\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003ePresenter: Darrell M. Gray, II, MD, MPH, FACG\u003cbr\u003e\nIntroduced by: David A. Greenwald, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nIdentify opportunities to enhance CRC screening uptake and improve CRC outcomes in diverse communities.\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e5:00 pm\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBreak\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e5:10 pm\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eSimultaneous Symposia: Session 4\u003cbr\u003e\n\u003csmall\u003eIn-person attendees can choose from three simultaneous symposia. One of the three symposia will be livestreamed for virtual attendees to view. All attendees will have access to on-demand recordings from each symposium following the conference.\u003c\/small\u003e\u003c\/strong\u003e\n\u003cp class=\"m-b-0\"\u003e\n\u003c\/p\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium 4A: Functional Esophageal Disorders: Managing Patients With Symptoms and Negative Testing\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Ronnie Fass, MD, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eFunctional Heartburn\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eRonnie Fass, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nDiscuss the diagnosis of functional heartburn and options for management.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFunctional Chest Pain\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eJohn O. Clarke, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nReview the approach to evaluation of non-cardiac chest pain, and the management of patients with chest pain and negative testing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFunctional Dysphagia\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eCharlene Prather, MD, MPH\u003c\/em\u003e\u003cbr\u003e\nDescribe the diagnostic approach and treatment options for functional dysphagia.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium 4B: Conundrums of Pancreatobiliary Diseases\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Linda S. Lee, MD\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHow Do I Get the Large Biliary Stone Out?\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eHarry R. Aslanian, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nDescribe how best to remove large biliary stones while minimizing risk of perforation and pancreatitis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePancreatic Cyst Management 101\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eLinda S. Lee, MD\u003c\/em\u003e\u003cbr\u003e\nDiscuss the different guidelines and how to approach pancreatic cyst management.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e2021 Updates in Diagnosing and Managing Biliary Strictures: Is It Malignant or Not? Stent Both Sides or Not?\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003ePhillip S. Ge, MD\u003c\/em\u003e\u003cbr\u003e\nExplain the advances in diagnosing indeterminate biliary strictures utilizing conventional techniques, FISH, DNA analysis, cholangioscopy, nCLE, and artificial intelligence; discuss how best to manage suspected hilar cholangiocarcinoma while avoiding potential pitfalls.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e6:25 pm\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eAnnual Scientific Meeting Adjourns for the Day\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ctable class=\"table table-schedule\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003e\u003c\/th\u003e\n\u003cth class=\"h3 text-uppercase\"\u003e\u003cb\u003eWednesday, October 27, 2021 | 8:30 am – 12:15 pm\u003c\/b\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:30 am\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eSimultaneous Plenary Sessions 4\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:15 am\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBreak\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:20 am\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eDavid Y. Graham Lecture\u003c\/strong\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eNavigating the Road From Precision to Prevention in IBD\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003ePresenter: Marla C. Dubinsky, MD\u003cbr\u003e\nIntroduced by: David A. Greenwald, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nDiscuss biomarkers for monitoring inflammation, using prognostic factors to guide IBD therapy, and explain the preclinical phase of IBD.\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:50 am\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBreak\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:00 am\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eSimultaneous Symposia: Session 5\u003cbr\u003e\n\u003csmall\u003eIn-person attendees can choose from two simultaneous symposia. One of the two symposia will be livestreamed for virtual attendees to view. All attendees will have access to on-demand recordings from both symposia following the conference.\u003c\/small\u003e\u003c\/strong\u003e\n\u003cp class=\"m-b-0\"\u003e\n\u003c\/p\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium 5A: Fecal Microbiota Transplantation at a Crossroads: Where Are We Now and Where Are We Going?\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Paul Feuerstadt, MD, FACG\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eA Clinician’s Crash Course to Understanding the Microbiota\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003ePaul Feuerstadt, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nReview what the microbiota is and how it is measured and evaluated, recognize what a “normal” microbiota consortium looks like, and define the most common terms used in this field.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThe Future of Microbiota Restoration in \u003cem\u003eC. difficile\u003c\/em\u003e Infections\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eSahil Khanna, MD, FACG\u003c\/em\u003e\u003cbr\u003e\nIdentify the newest investigational microbiota replacement therapy products used to treat \u003cem\u003eC. difficile\u003c\/em\u003e infection.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMicrobiota Restoration in Inflammatory Bowel Disease, Irritable Bowel Syndrome, and Liver Disease\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eOlga C. Aroniadis, MD, MSc\u003c\/em\u003e\u003cbr\u003e\nDescribe the alterations in the microbiota seen in non-\u003cem\u003eC. difficile\u003c\/em\u003e infection gastrointestinal diseases, and explain what the next 1-2 years of research might look like with regard to applying microbiota therapy to these disease states.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"m-b-0\"\u003e\u003cstrong\u003eSymposium 5B: Recent Developments in Esophageal Motility Disorders\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eModerator: Katarina B. Greer, MD, MS Epi\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAchalasia Guideline: Breaking It Down – Diagnosis, Pearls, Subtype, Management\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eKatarina B. Greer, MD, MS Epi\u003c\/em\u003e\u003cbr\u003e\nDiscuss the common subtypes of achalasia, diagnosis and best management strategies, and how to manage treatment failures.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThe New Chicago Classification Version 4.0: Implications for Clinical Practice\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eJohn E. Pandolfino, MD, MSCI, FACG\u003c\/em\u003e\u003cbr\u003e\nReview the new Chicago classification of esophageal motility disorders and discuss its implications for clinical practice.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEGJOO and Opioid-Induced Esophageal Dysfunction: Extra Considerations in Diagnosis, Treatment, and Management\u003c\/strong\u003e\u003cbr\u003e\n\u003cem\u003eMarcelo F. Vela, MD, MSCR, FACG\u003c\/em\u003e\u003cbr\u003e\nDescribe esophagogastric junction outflow obstruction diagnosis, differential diagnosis, and management options.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:15 pm\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eAnnual Scientific Meeting Adjourns\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954643570786,"sku":"MED-AMB07403","price":60.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/ACG-Annual-Scientific-Meeting-2021-scaled-768x768-1.jpg?v=1779381497","url":"https:\/\/meducourse.com\/products\/acg-annual-scientific-meeting-2021","provider":"Meducourse","version":"1.0","type":"link"}